IL5 and glioblastoma: The IFN-γ/IL-5 ratios in both primary GBM patients (geometric mean 3.7) and recurrent GBMs (geometric mean 0.9) were significantly lower than those in healthy subjects (geometric mean 16.0) and meningioma patients (geometric mean 10.0) (p<0.001).